The consequence is that the ECM remodelling associated with obesity may be maladaptive, resulting in the accumulation of ECM molecules and the activation of ECM membrane receptors (e.g. integrins and CD44) [2–8]. This evidence concerns the gene CD44 and obesity due to melanocortin 4 receptor deficiency.